Study2015

Neuroprotective effect of sulforaphane against methylglyoxal cytotoxicity

Angeloni C, Malaguti M, Rizzo B, Barbalace MC, Fabbri D, Hrelia S

Chemical research in toxicology · 82 citations

Review labels

Mechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
In vitro/mechanistic study (classified by our AI screen)
Studied in
Cells or lab samples
Main outcome
Mechanisms only

Who paid for it

Funding
Independent funding
Government
Ministero dell'Istruzione, dell'Università e della Ricerca

Based on 1 listed funder(s).

Publication

Published
2015-05-01 · Chem Res Toxicol · vol. 28 · issue 6 · pp. 1234–1245
Publisher
American Chemical Society
Cited
92 citations · more than 93% of similar papers · 3.4× the field average
Impact
Top 10% most cited in its field
References
95 works
Access
Open access (repository copy) · OTHER-OA
Research areas
Genomics, phytochemicals, and oxidative stress · Biochemical Acid Research Studies · Nuclear Receptors and Signaling
Keywords
Sulforaphane, Methylglyoxal, Cytotoxicity, Neuroprotection, Chemistry, Pharmacology, Biochemistry, Medicine, In vitro
MeSH
tumor cells, cultured, humans, pyruvaldehyde, isothiocyanates, sulfoxides, glucose, neuroprotective agents, apoptosis, structure-activity relationship, oxidative stress, dose-response relationship, drug

6 authors

From IT

  • Cristina Angeloni · correspondingUniversity of Bologna
  • Marco MalagutiUniversity of Bologna
  • Benedetta RizzoUniversity of Bologna
  • Maria Cristina BarbalaceUniversity of Bologna
  • Daniele FabbriUniversity of Bologna
  • Silvana HreliaUniversity of Bologna

Abstract

Glycation, an endogenous process that leads to the production of advanced glycation end products (AGEs), plays a role in the etiopathogenesis of different neurodegenerative diseases, such as Alzheimer's disease (AD). Methylglyoxal is the most potent precursor of AGEs, and high levels of methylglyoxal have been found in the cerebrospinal fluid of AD patients. Methylglyoxal may contribute to AD both inducing extensive protein cross-linking and mediating oxidative stress. The aim of this study was to investigate the role of sulforaphane, an isothiocyanate found in cruciferous vegetables, in counteracting methylglyoxal-induced damage in SH-SY5Y neuroblastoma cells. The data demonstrated that sulforaphane protects cells against glycative damage by inhibiting activation of the caspase-3 enzyme, reducing the phosphorylation of MAPK signaling pathways (ERK1/2, JNK, and p38), reducing oxidative stress, and increasing intracellular glutathione levels. For the first time, we demonstrate that sulforaphane enhances the methylglyoxal detoxifying system, increasing the expression and activity of glyoxalase 1. Sulforaphane modulated brain-derived neurotrophic factor and its pathway, whose dysregulation is related to AD development. Moreover, sulforaphane was able to revert the reduction of glucose uptake caused by methylglyoxal. In conclusion, sulforaphane demonstrates pleiotropic behavior thanks to its ability to act on different cellular targets, suggesting a potential role in preventing/counteracting multifactorial neurodegenerative diseases such as Alzheimer's.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.